Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Manchester Evening News
Manchester Evening News
National
Helen Carter

Pfizer vaccine approval paves way for mass UK vaccination programme 'early next week'

A mass coronavirus vaccination programme is set to start in the UK 'early next week' - after the Pfizer vaccine was approved for use.

A coronavirus vaccine from Pfizer/BioNTech has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK.

In November, the MHRA was formally asked by the UK government to assess the vaccine, which the company reported had 94.5 per cent efficacy in clinical trials.

Officials said the vaccine will be made available "from next week" and Health Secretary Matt Hancock tweeted that the NHS was ready to start 'early next week'.

A Department of Health and Social Care spokesman said: “The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer/BioNTech’s Covid-19 vaccine for use.

"This follows months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness.

“The Joint Committee on Vaccination and Immunisation (JCVI) will shortly also publish its latest advice for the priority groups to receive the vaccine, including care home residents, health and care staff, the elderly and the clinically extremely vulnerable.

“The vaccine will be made available across the UK from next week.”

The coronavirus vaccine being produced by BioNTech (PA)

The Department of Health and Social Care spokesman added: “The NHS has decades of experience in delivering large-scale vaccination programmes and will begin putting their extensive preparations into action to provide care and support to all those eligible for vaccination.

“To aid the success of the vaccination programme it is vital everyone continues to play their part and abide by the necessary restrictions in their area so we can further suppress the virus and allow the NHS to do its work without being overwhelmed.

“Further details will be set out shortly."

Pfizer/BioNTech said its vaccine had observed efficacy in adults over 65 of more than 94.5 per cent.

Health Secretary Matt Hancock tweeted: “Help is on its way. The MHRA has formally authorised the Pfizer/BioNTech vaccine for Covid-19.

“The NHS stands ready to start vaccinating early next week.

“The UK is the first country in the world to have a clinically approved vaccine for supply.”

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.